November 30, 2023

World AIDS Day: Research from Across Mass General Brigham

November 29, 2023 December 1 marks the 35th commemoration of World AIDS Day, an annual event that reminds us that HIV and HIV-related stigma remain public […]
November 16, 2023

Use of statins in individuals with HIV and low cardiovascular risk: the next stop along the route to optimized risk management

By Iulia Filip The puzzle of cardiovascular (CV) risk reduction in people with HIV (PWH) is a hard one to solve in the absence of CV risk […]
November 15, 2023

Pitavastatin lowers plaque volume, progression in lower-risk patients with HIV

By Erik Swain Pitavastatin lowered noncalcified plaque volume and reduced risk for plaque progression compared with placebo in patients with HIV at low to moderate risk […]
October 4, 2023

For people with HIV, statins show 35 percent drop in heart attack risk

By Linda Searing Although people living with HIV have a greatly increased risk for cardiovascular issues, such as blocked arteries, heart attacks and stroke, new research has found […]
September 12, 2023

For ‘Silver Tsunami’ With H.I.V., New Hope for Healthy Aging

By Benjamin Ryan A recent study showed that a statin drug significantly lowered the risk of heart attacks and strokes among middle-aged and older people with […]
August 17, 2023

Preventing HIV’s Collateral Cardiovascular Damage

People living with HIV have increased risk for cardiovascular disease (and other diseases of aging) earlier in life than those without HIV. In this episode of […]
August 4, 2023

Statins and HIV: how can the REPRIEVE findings be implemented in the real world?

By Liz Highleyman Findings from the landmark REPRIEVE trial, which tested a daily statin medication for people living with HIV, were presented on Monday at the 12th […]
August 4, 2023

Pitavastatin Prevented Cardiovascular Events in People with HIV

By Rajesh T. Gandhi A randomized trial demonstrates that even those PWH at low-to-moderate risk for cardiovascular disease benefit from starting pitavastatin. Read the full article […]
August 4, 2023

REPRIEVE Trial Highlights Shift in HIV Care from ID to General Medicine

By Paul Sax The biggest news this week at the 12th IAS Conference on HIV Science here in Brisbane, Australia, was the results of REPRIEVE, a large […]